Recent insights into the regulation of cerebral circulation

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 6-7, 1996, Pages 449-457

  Brian Jr , Johnny E ^a   Faraci, Frank M ^a   Heistad, Donald D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

autoregulation; calcitonin gene related peptide; cerebral circulation; endothelin; flow metabolism; hypercapnia; nitric oxide; potassium channel

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP; ENDOTHELIN; ENDOTOXIN; EXCITATORY AMINO ACID; NITRIC OXIDE;

AUTOREGULATION; BRAIN BLOOD FLOW; HYPERCAPNIA; HYPOTENSION; REGULATORY MECHANISM; SEIZURE; SHORT SURVEY; SOMATOSENSORY STIMULATION; VASODILATATION;

EID: 0029890160     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02760.x     Document Type: Short Survey

References (111)

1. Faraci FM, Brian JE Jr. Nitric oxide in the cerebral circulation. Stroke 1994; 25: 692-703.
2. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J. Cereb. Blood Flow Metab. 1994; 14: 175-92.
3. Moskowitz MA, Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc. Brain Metab. Rev. 1993; 5: 159-77.
4. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 1995; 268: C799-822.
5. Kitazono T, Faraci FM, Taguchi H, Heistad DD. Role of potassium channels in cerebral blood vessels. Stroke 1995; 26: 1713-23.
6. Levin ER. Endothelins. N. Engl. J. Med. 1995; 333: 356-63.
7. Nathan C, Xie Q. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 1994; 269: 13 725-8.
8. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992; 6: 3051-64.
9. Brian JE Jr, Heistad DD, Faraci FM. Dilatation of cerebral arterioles to lipopolysaccharide in vivo. Stroke 1995; 26: 277-81.
10. Brian JE Jr, Heistad DD, Faraci FM. Mechanisms of endotoxin-induced dilatation of cerebral arterioles. Am. J. Physiol. 1995; 269: H783-8.
11. Koedel U, Bernatowicz A, Paul R, Frei K, Fontana A, Pfister H-W. Experimental pneumococcal meningitis: Cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann. Neurol. 1995; 37: 313-23.
12. Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 1992; 8: 3-11.
13. Estrada C, Mengual E, González C. Local NADPH-diaphorase neurons innervate pial arteries and lie close or project to intracerebral blood vessels: A possible role for nitric oxide in the regulation of cerebral blood flow. J. Cereb. Blood Flow Metab. 1993; 18: 978-84.
14. Tracey WR, Nakane M, Pollock JS, Förstermann U. Nitric oxide synthases in neuronal cells, macrophages and endothelium are NADPH diaphorases, but represent only a fraction of total cellular NADPH diaphorase activity. Biochem. Biophys. Res. Commun. 1993; 195: 1035-40.
15. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 1991; 7: 615-24.
16. Nozaki K, Moskowitz MA, Maynard KI et al. Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries. J. Cereb. Blood Flow Metab. 1993; 13: 70-9.
17. Yoshida K, Okamura T, Kimura H, Bredt DS, Snyder SH, Toda N. Nitric oxide synthase-immunoreactive nerve fibers in dog cerebral and peripheral arteries. Brain Res. 1993; 629: 67-72.
18. Toda N, Ayajiki K, Okamura T. Cerebroarterial relaxations mediated by nitric oxide derived from endothelium and vasodilator nerve. J Vasc. Res. 1993; 30: 61-7.
19. Murphy S, Simmons ML, Agullo L et al. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 1993; 16: 323-8.
20. Murphy S, Rich G, Orgren KI, Moore SA, Faraci FM. Astrocyte-derived lipoxygenase product evokes endothelium-dependent relaxation of the basilar artery. J. Neurosci. Res. 1994; 38: 314-18.
21. Brian JE Jr, Kennedy RH. Modulation of cerebral arterial tone by endothelium-derived relaxing factor. Am. J. Physiol. 1993; 264: H1245-50.
22. G-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat. J. Physiol. 1992; 449: 183-96.
23. Irikura K, Maynard KI, Moskowitz MA. Importance of nitric oxide synthase inhibition to the attenuated vascular responses induced by topical L-nitroarginine during vibrissal stimulation. J. Cereb. Blood Flow Metab. 1994; 14: 45-8.
24. Northington FJ, Metherne GP, Berne RM. Competitive inhibition of nitric oxide synthase prevents the cortical hyperemia associated with peripheral nerve stimulation. Proc. Natl Acad. Sci. USA 1992; 89: 6649-52.
25. Faraci FM, Breese KR, Heistad DD. Nitric oxide contributes to dilation of cerebral arterioles during seizures. Am. J. Physiol. 1993; 265: H2209-12.
26. Iadecola C, Zhang F. Nitric oxide-dependent and -independent components of cerebrovasodilation elicited by hypercapnia. Am. J. Physiol. 1994; 266: R546-52.
27. Faraci FM, Breese KR, Heistad DD. Cerebral vasodilatation during hypercapnia: Role of glibenclamide-sensitive potassium channels and nitric oxide. Stroke 1994; 25: 1679-83.
28. Iadecola C, Xu X. Nitro-L-arginine attenuates hypercapnic cerebrovasodilation without affecting cerebral metabolism. Am. J. Physiol. 1994; 266: R518-25.
29. 2 in vivo. J. Cereb. Blood Flow Metab. 1994; 14: 944-51.
30. Niwa K, Lindauer U, Villringer A, Dirnagl U. Blockade of nitric oxide synthesis in rats strongly attenuates the CBF response to extracellular acidosis. J. Cereb. Blood Flow Metab. 1993; 13: 535-9.
31. Toda N, Hatano Y, Mori K. Mechanisms underlying response to hypercapnia and bicarbonate of isolated dog cerebral arteries. Am. J. Physiol. 1989; 257: H141-6.
32. Iadecola C, Zhang F, Xu X. Role of nitric oxide synthase-containing vascular nerves in cerebrovasodilatation elicited from cerebellum. Am. J. Physiol. 1993; 264: R738-46.
33. Fabricius M, Lauritzen M. Examination of the role of nitric oxide for the hypercapnic rise of cerebral blood flow in rats. Am. J. Physiol. 1994; 266: H1457-64.
34. Wang Q, Pelligrino DA, Baughman VL, Koenig HM, Albrecht RF. The role of neuronal nitirc oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J. Cereb. Blood Flow Metab. 1995; 15: 774-8.
35. Iadecola C, Zhang F, Xu X. SIN-1 reverses attenuation of hypercapnic cerebrovasodilation by nitric oxide synthase inhibitors. Am. J. Physiol. 1994; 267: R228-35.
36. Faraci FM, Breese KR, Heistad DD. Responses of cerebral arterioles to kainate. Stroke 1994; 25: 2080-4.
37. Faraci FM, Breese KR. Nitric oxide mediates vasodilation in response to activation of N-methyl-D-aspartate receptors in brain. Circ. Res. 1993; 72: 476-80.
38. Meng W, Tobin JR, Busija DW. Glutamate-induced cerebral vasodilation is mediated by nitric oxide through N-methyl-D-aspartate receptors. Stroke 1995; 26: 857-63.
39. Faraci FM, Brian JE Jr. 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to NMDA. Stroke 1995; 26: 2172-6.
40. Li J, Iadecola C. Nitric oxide and adenosine mediate vasodilation during functional activation in cerebellar cortex. Neuropharmacology 1994; 33: 1453-61.
41. Adachi K, Takahashi S, Melzer P et al. Increases in local cerebral blood flow associated with somatosensory activation are not mediated by NO. Am. J. Physiol. 1993; 267: H2155-62.
42. Dirnagl U, Lindauer U, Villringer A. Role of nitric oxide in the coupling of cerebral blood flow to neuronal activation in rats. Neurosci. Lett. 1993; 149: 43-6.
43. Wang Q, Kjaer T, Jorgensen MB et al. Nitric oxide does not act as a mediator coupling cerebral blood flow to neural activity following somatosensory stimuli in rats. Neurol. Res. 1993; 15: 33-6.
44. Iadecola C. Nitric oxide participates in the cerebrovasodilation elicited from cerebellar fastigial nucleus. Am. J. Physiol. 1992; 263: R1156-61.
45. Wahl M, Schilling L, Parsons AA, Kaumann A. Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res. 1994; 637: 204-10.
46. Zhang ZG, Chopp M, Maynard KI, Moskowitz MA. Cerebral blood flow changes during cortical spreading depression are not altered by inhibition of nitric oxide synthesis. J. Cereb. Blood Flow Metab. 1994; 14: 939-43.
47. Lauritzen M, Hansen AJ. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J. Cereb. Blood Flow Metab. 1992; 12: 223-9.
48. Traystman RJ, Moore LE, Helfaer MA et al. Nitro-L-arginine analogues dose- and time-related nitric oxide synthase inhibition in brain. Stroke 1995; 26: 864-9.
49. Durieu-Trautmann O, Fédérici C, Créminon C et al. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: Regulation by cyclic nucleotides. J. Cell. Physiol. 1993; 155: 104-11.
50. Minc-Golomb D, Tsarfaty I, Schwartz JP. Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine. Br. J. Pharmacol. 1994; 112: 720-2.
51. Haberl RL, Anneser F, Ködel U, Pfister H-W. Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis? Neurol. Res. 1994; 16: 108-12.
52. 2 in Haemophilus influenzae type b meningitis in rabbits. Am. J. Physiol. 1994; 266: H1755-61.
53. Park KS, Lee HW, Hong S-Y, Shin N, Kim S, Paik WK. Determination of methylated amino acids in human serum by high-performance liquid chromatography. J. Chromatogr. 1988; 440: 225-30.
54. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J. Cardiovasc. Pharmacol. 1992; 20 (Suppl. 12): S60-2.
55. Ueno S, Sano A, Kotani K, Kondoh K, Kakimoto Y. Distribution of free methylarginines in rat tissues and in the bovine brain. J. Neurochem. 1992; 59: 2012-16.
56. Faraci FM, Brian JE Jr, Heistad DD. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am. J. Physiol. 1995; 269: H1522-7.
57. Edwards RM, Stack EJ, Trizna W. Calcitonin gene-related peptide stimulates adenylate cyclase and relaxes intracerebral arterioles. J. Pharmacol. Exp. Ther. 1991; 257: 1020-4.
58. + channels in CGRP-induced dilation of basilar artery in vivo. Am. J. Physiol. 1993; 265: H581-5.
59. McCulloch J, Uddman R, Kingman TA, Edvinsson L. Calcitonin gene-related peptide: Functional role in cerebrovascular regulation. Proc. Natl Acad. Sci. USA 1986; 83: 5731-5.
60. Edvinsson L, Ekman R, Jansen I, McCulloch J, Uddman R. Calcitonin gene-related peptide and cerebral blood vessels: Distribution and vasomotor effects. J. Cereb. Blood Flow Metab. 1987; 7: 720-8.
61. Moskowitz MA, Wei EP, Saito K, Kontos HA. Trigeminalectomy modifies pial arteriolar responses to hypertension or norepinephrine. Am. J. Physiol. 1988; 255: H1-6.
62. Moskowitz MA, Sakas DE, Wei EP et al. Postocclusive cerebral hyperemia is markedly attenuated by chronic trigeminal ganglionectomy. Am. J. Physiol. 1989; 257: H1736-9.
63. Wei EP, Moskowitz MA, Boccalini P, Kontos HA. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilatation in feline cerebral arterioles. Circ. Res. 1992; 70: 1313-19.
64. Hong KW, Pyo KM, Lee WS, Yu SS, Rhim BY. Pharmacological evidence that Calcitonin gene-related peptide is implicated in cerebral autoregulation. Am. J. Physiol. 1994; 266: H11-16.
65. Hongo K, Tsukahara T, Kassell NF, Ogawa H. Effect of subarachnoid hemorrhage on Calcitonin gene-related peptide-induced relaxation in rabbit basilar artery. Stroke 1989; 20: 100-4.
66. Faraci FM, Breese KR. Dilatation of cerebral arterioles in response to N-methyl-D-aspartate: Role of CGRP and acetylcholine. Brain Res. 1994; 640: 93-7.
67. Ayajiki K, Okamura T, Toda N. Neurogenic relaxations caused by nicotine in isolated cat middle cerebral arteries. J. Pharmacol. Exp. Ther. 1994; 270: 795-801.
68. Sakas DE, Moskowitz MA, Wei EP, Kontos HA, Kano M, Oglivy CS. Trigeminovascular fibers increase blood flow in cortical gray matter by axon reflex-like mechanisms during acute severe hypertension or seizures. Proc. Natl Acad. Sci. USA 1989; 86: 1401-5.
69. Pfister H-W, Kümpfel T, Koedel U. Involvement of substance P in pial arteriolar vasodilatation during pneumococcal meningitis in the rat. Neuroreport 1995; 6: 1301-5.
70. Liu-Chen L-Y, Liszczak TM, King JC, Moskowitz MA. Immunoelectron microscopic study of substance P-containing fibers in feline cerebral arteries. Brain Res. 1986; 369: 12-20.
71. Moskowitz MA, Brody M, Liu-Chen L-Y. In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neuroscience 1983; 9: 809-14.
72. Faraci FM, Kadel KA, Heistad DD. Vascular responses of dura mater. Am. J. Physiol. 1989; 257: H157-61.
73. Jansen I, Alafaci C, McCulloch J, Uddman R, Edvinsson L. Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: Vasomotor responses in vitro and in situ. J. Cereb. Blood Flow Metab. 1991; 11: 567-75.
74. Rosenblum WI, Shimuizu T, Nelson GH. Endothelium-dependent effects of substance P and Calcitonin gene-related peptide on mouse pial arterioles. Stroke 1993; 24: 1043-8.
75. O'Shaughnessy CT, Waldron GJ, Connor HE. Lack of effect of sumatriptan and UK-14304 on capsaicin-induced relaxation of guinea-pig isolated basilar artery. Br. J. Pharmacol. 1993; 108: 191-5.
76. Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated leakage of plasma protein occurs form blood vessels in dura mater but not brain. J. Neurosci. 1987; 7: 4129-36.
77. Edvinsson L, Brodin E, Jansen I, Uddman R. Neurokinin A in cerebral vessels: Characterization, localization and effect in vitro. Regul. Pept. 1988; 20: 181-97.
78. Shinmi O, Kamura S, Sawamura T et al. Endothelin-3 is a novel neuropeptide: Isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brain. Biochem. Biophys. Res. Commun. 1989; 164: 587-93.
79. Sakurai T, Yanagisawa M, Takuwa Y et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990; 348: 732-5.
80. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-2.
81. 125I ET-1, ET-2, and ET-3 and vasoactive intestinal contractor are present in adult rat brain and neurone-enriched primary cultures of embryonic brain cells. Brain Res. 1991; 554: 278-85.
82. MacCumber MW, Ross CA, Snyder SH. Endothelin in brain: Receptors, mitogenesis, and biosynthesis in glial cells. Proc. Natl Acad. Sci. USA 1990; 87: 2359-63.
83. Kitazono T, Heistad DD, Faraci FM. Enhanced responses of the basilar artery to activation of endothelin B receptors in strokeprone spontaneously hypertensive rats. Hypertension 1995; 25: 490-4.
84. Faraci FM. Effects of endothelin and vasopressin on cerebral blood vessels. Am. J. Physiol. 1989; 257: H799-803.
85. Kitazono T, Heistad DD, Faraci FM. Dilatation of the basilar artery in response to selective activation of endothelin B receptors in vivo. J. Pharmacol. Exp. Ther. 1995; 273: 1-6.
86. A receptors. Brain Res. 1994; 658: 179-84.
87. Murray MA, Faraci FM, Heistad DD. Effect of protein kinase C inhibitors on endothelium- and vasopressin-induced constriction of the rat basilar artery. Am. J. Physiol. 1992; 263: H1643-49.
88. Ogura K, Takayasu M, Dacey RG Jr. Differential effects of intra-and extraluminal endothelin on cerebral arterioles. Am. J. Physiol. 1991; 261: H531-7.
89. Kadel KA, Heistad DD, Faraci FM. Effects of endothelin on blood vessels of the brain and choroid plexus. Brain Res. 1990; 518: 78-82.
90. Foley PL, Caner HH, Kassell NF, Lee KS. Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery 1994; 34: 108-13.
91. Seifert V, Löffler B-M, Zimmermann M, Roux S, Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 1995; 82: 55-62.
92. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci. 1993; 52: 825-34.
93. Hirose H, Ide K, Sasaki T et al. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Eur. J. Pharmacol. 1995; 277: 77-87.
94. Kasuya H, Weir BKA, White DM, Steffansson K. Mechanisms of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J. Neurosurg. 1993; 79: 892-8.
95. Gaetani P, Rodriguez y Baena R, Grignani G, Spanu G, Pacchiarini L, Paoletti P. Endothelin and aneurysmal subarachnoid haemorrhage: A study of subarachnoid cisternal cerebrospinal fluid. J. Neurol. Neurosurg. Psychiatry 1994; 57: 66-72.
96. A-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J. Cardiovasc. Pharmacol. 1993; 22 (Suppl. 8): S332-5.
97. + channels in arterial smooth muscle. Science 1989; 245: 177-80.
98. Faraci FM, Heistad DD. Role of ATP-sensitive potassium channels in the basilar artery. Am. J. Physiol. 1993; 264: H8-13.
99. Brayden JE. Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation. Am. J. Physiol. 1990; 259: H668-73.
100. Kitazono T, Faraci FM, Heistad DD. Effect of norepinephrine on rat basilar artery in vivo. Am. J. Physiol. 1993; 264: H178-82.
101. + channels mediate dilatation of cerebral arterioles during hypoxia. Circ. Res. 1994; 74: 1005-8.
102. Lee WS, Kwon YJ, Yu SS, Rhim BY, Hong KW. Disturbances in autoregulatory responses of rat pial arteries by sulfonylureas. Life Sci. 1993; 52: 1527-34.
103. Pearce WJ. Mechanisms of hypoxic cerebral vasodilatation. Pharmacol. Ther. 1995; 65: 75-91.
104. Mayhan WG. Effect of diabetes mellitus on response of the basilar artery to activation of ATP-sensitive potassium channels. Brain Res. 1994; 636: 35-9.
105. Kitazono T, Heistad DD, Faraci FM. ATP-sensitive potassium channels in the basilar artery during chronic hypertension. Hypertension 1993; 22: 677-81.
106. + channels in cat cerebral arterial muscle cell membranes. Pflügers Arch. 1994; 428: 621-30.
107. + channels. Biochem. Biophys. Res. Commun. 1991; 181: 172-8.
108. + channels. Cardiovasc. Drugs Ther. 1993; 7: 605-10.
109. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 1992; 256: 532-5.
110. + channels in the resting state of cerebral, coronary and mesenteric arteries of the dog. J. Pharmacol. Exp. Ther. 1993; 267: 1277-85.
111. + channels. Circ. Res. 1995; 76: 1057-62.